Adaptive Biotechnologies Corporation company logo
Adaptive Biotechnologies Corporation logo

ADPT Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$47.92M$17.14M-26.35%

Summary

Current Value
As of today, ADPT annual cash & cash equivalents is $47.92M, down -26.35% on
Historical Performance
ADPT annual cash & cash equivalents is down -65.54% over the past 3 years, and down -50.38% over the past 5 years
All-Time High Comparison
ADPT annual cash & cash equivalents is currently -65.54% below its historical high of $139.07M set on
3-Year Low Comparison
ADPT annual cash & cash equivalents is at its 3-year low
Sector Comparison
ADPT annual cash & cash equivalents is higher than 51.06% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

ADPT Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$47.92M-26.4%-65.5%-50.4%-43.8%
Quarterly Cash & Cash Equivalents$212.77M-12.6%-58.1%-74.5%
Price$18.26+180.9%+89.0%-70.8%
Annual Current Assets$283.75M-30.8%-29.6%-53.7%+38.3%
Annual Total Liabilities$336.89M-4.5%+5.5%-1.3%-42.6%
Annual Working Capital$185.70M-42.4%-35.7%-65.3%+0.8%
Annual Net Income-$159.60M+29.2%+23.0%-129.4%-273.8%

Cash and Cash Equivalents Highs

ADPT Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$90.03MN/A-46.8%
5Y$139.07M-65.5%
All$139.07M-65.5%

Cash and Cash Equivalents Lows

ADPT Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$47.92Mat low
5Y$47.92Mat low
All$47.92Mat low

Cash and Cash Equivalents History

YearValueChange
$47.92M-26.3%
$65.06M-27.7%
$90.03M-35.3%
$139.07M+12.7%
YearValueChange
$123.44M+27.8%
$96.58M+75.5%
$55.03M-35.5%
$85.31M-

FAQ

  • What is the current annual cash & cash equivalents of ADPT?

    As of today, ADPT annual cash & cash equivalents is $47.92M

  • What is 1-year change in ADPT annual cash & cash equivalents?

    ADPT annual cash & cash equivalents is down -26.35% year-over-year

  • What is 3-year change in ADPT annual cash & cash equivalents?

    ADPT annual cash & cash equivalents is down -65.54% over the past 3 years

  • How far is ADPT annual cash & cash equivalents from its all-time high?

    ADPT annual cash & cash equivalents is currently -65.54% below its historical high of $139.07M set on December 31, 2021

  • How does ADPT annual cash & cash equivalents rank versus sector peers?

    ADPT annual cash & cash equivalents is higher than 51.06% of companies in Healthcare sector

  • When is ADPT next annual earnings release?

    The next annual earnings release for ADPT is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. ADPT Official Website www.adaptivebiotech.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1478320/000119312525267061/0001193125-25-267061-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1478320/000095017025030913/0000950170-25-030913-index.htm
  4. ADPT Profile on Yahoo Finance finance.yahoo.com/quote/ADPT
  5. ADPT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/adpt